Synopsis of recent research by authors named "Shanli Zhu"
Shanli Zhu's recent research primarily focuses on the development of novel therapeutic and diagnostic agents, including affibody molecules and chimeric virus-like particles, targeting various cancers and infectious diseases like SARS-CoV-2 and Chlamydia trachomatis.
Key findings highlight the efficacy of these agents in tumor-targeting, immune responses against viral infections, and potential applications in both prevention and treatment strategies.
The research also explores the influence of non-nutritive sweeteners on health, illustrating a comprehensive approach to understand the biochemical interactions affecting cancer progression and metabolic regulation.